Your browser doesn't support javascript.
loading
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.
Zeidan, Amer M; Platzbecker, Uwe; Bewersdorf, Jan Philipp; Stahl, Maximilian; Adès, Lionel; Borate, Uma; Bowen, David; Buckstein, Rena; Brunner, Andrew; Carraway, Hetty E; Daver, Naval; Díez-Campelo, Maria; de Witte, Theo; DeZern, Amy E; Efficace, Fabio; Garcia-Manero, Guillermo; Garcia, Jacqueline S; Germing, Ulrich; Giagounidis, Aristoteles; Griffiths, Elizabeth A; Hasserjian, Robert P; Hellström-Lindberg, Eva; Iastrebner, Marcelo; Komrokji, Rami; Kulasekararaj, Austin G; Malcovati, Luca; Miyazaki, Yasushi; Odenike, Olatoyosi; Santini, Valeria; Sanz, Guillermo; Scheinberg, Phillip; Stauder, Reinhard; van de Loosdrecht, Arjan A; Wei, Andrew H; Sekeres, Mikkael A; Fenaux, Pierre.
Afiliação
  • Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT.
  • Platzbecker U; Leipzig University Hospital, Leipzig, Germany.
  • Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Harvard University, Boston, MA.
  • Adès L; Service d'hématologie, Hôpital Saint-Louis (Assistance Publique Hôpitaux de Paris) and Université de Paris-Cité, Paris, France.
  • Borate U; Division of Hematology, Department of Internal Medicine, James Cancer Center, The Ohio State University, Columbus, OH.
  • Bowen D; St James's Institute of Oncology, Leeds, United Kingdom.
  • Buckstein R; Division of Oncology and Malignant Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Brunner A; Leukemia Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Harvard University, Boston, MA.
  • Carraway HE; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Díez-Campelo M; Hematology Department, University Hospital of Salamanca, Institute for Biomedical Research of Salamanca, Universidad de Salamanca, Salamanca, Spain.
  • de Witte T; Department of Tumor Immunology, Radboud Institute of Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • DeZern AE; Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre, Baltimore, MD.
  • Efficace F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Harvard University, Boston, MA.
  • Germing U; Klinik für Hämatologie, Onkologie und klinische Immunologie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
  • Giagounidis A; St Mary's Hospital, Düsseldorf, Germany.
  • Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Hellström-Lindberg E; Karolinska Institutet, Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska University Hospital, Stockholm, Sweden.
  • Iastrebner M; Sanatorio Universitario Sagrado Corazón, Ciudad Autónoma de Buenos Aires, Argentina.
  • Komrokji R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Kulasekararaj AG; Department of Haematological Medicine, King's College Hospital, National Institute of Health Research/Wellcome King's Clinical Research Facility and King's College London, London, United Kingdom.
  • Malcovati L; Department of Hematology, University of Pavia & IRCCS S. Matteo Hospital Foundation, Pavia, Italy.
  • Miyazaki Y; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL.
  • Santini V; MDS Unit, AOUC, University of Florence, Florence, Italy.
  • Sanz G; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain, Health Research Institute La Fe, Valencia, Spain; and CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Scheinberg P; Division of Hematology, Hospital A Beneficência Portuguesa, São Paulo, Brazil.
  • Stauder R; Department of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria.
  • van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Medical Center, Amsterdam Cancer Center, Amsterdam, The Netherlands.
  • Wei AH; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne and Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
  • Sekeres MA; Division of Hematology, Sylvester Comprehensive Cancer Center, Miami Miller School of Medicine, University of Miami, Miami, FL.
  • Fenaux P; Service d'hématologie, Hôpital Saint-Louis (Assistance Publique Hôpitaux de Paris) and Université de Paris-Cité, Paris, France.
Blood ; 141(17): 2047-2061, 2023 04 27.
Article em En | MEDLINE | ID: mdl-36724453
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Hematologia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Hematologia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article